Bradley Sitko
Chief Investment Officer at XOMA CORPORATION
Net worth: 230 056 $ as of 2024-04-29
Profile
Bradley J.
Sitko is currently a Managing Director at RTW Investments and a Chief Investment Officer at XOMA Corp.
He was previously a Director at MTS Health Partners LP from 2008 to 2015, a Vice President-Finance & Corporate Development at DNAnexus, Inc. from 2015 to 2019, and a Director at RTW Investments ICAV from 2021 to 2023.
He also held a position as a Chief Financial Officer at Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
Additionally, he has worked as a Principal at Pfizer Inc. Mr. Sitko received his undergraduate degree from the University of Pennsylvania and his MBA from Columbia Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
XOMA CORPORATION
0.06% | 2024-03-17 | 7,100 ( 0.06% ) | 180 056 $ | 2024-04-29 |
2023-10-01 | 2,000 ( 0.13% ) | 50 000 $ | 2024-04-29 |
Bradley Sitko active positions
Companies | Position | Start |
---|---|---|
XOMA CORPORATION | Chief Investment Officer | 2023-01-02 |
RTW Investments /Venture/
RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Private Equity Investor | 2019-10-31 |
Former positions of Bradley Sitko
Companies | Position | End |
---|---|---|
RTW Investments ICAV | Director/Board Member | 2022-12-31 |
DNAnexus, Inc.
DNAnexus, Inc. Packaged SoftwareTechnology Services DNAnexus, Inc. develops a cloud-based data analysis and management platform for DNA sequence data. It engages in the provision of cloud-based solutions for large-scale Deoxyribonucleic acid (DNA) data management and analysis. The firm offers a centralized hub for managing data, collaborating with other scientists, sharing tools, and accessing diverse reference datasets, including genotypic and phenotypic data. The company was founded by Serafim Batzoglou, Andreas Sundquist and Arend Sidow in 2009 and is headquartered in Mountain View, CA. | Director of Finance/CFO | 2018-12-31 |
MTS Health Partners LP
MTS Health Partners LP Investment Banks/BrokersFinance MTS Health Partners LP provides strategic and financial advisory services to healthcare companies from global corporations to venture backed businesses. Its strategic advisory alternatives include mergers, acquisitions, company sales, divestitures, recapitalizations, restructurings, general strategic advisory, financing oversight and oversight opinions. The firms financing solutions include traditional private convertible preferred issuances, cross-over focused convertible transactions, common stock and structured/convertible PIPEs, registered direct and acquisition financings, secondary sales, special situations, structured debt financings and royalty monetization. The company was founded by Curtis Scott Lane in 2000 and is headquartered in New York, NY. | Director/Board Member | 2015-02-28 |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. is a Chinese company that develops and commercializes novel therapeutics. Yan Ping Mou has been the CEO of the company since 2023. | Director of Finance/CFO | - |
PFIZER, INC. | Corporate Officer/Principal | - |
Training of Bradley Sitko
University of Pennsylvania | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
PFIZER, INC. | Health Technology |
XOMA CORPORATION | Health Technology |
Private companies | 5 |
---|---|
MTS Health Partners LP
MTS Health Partners LP Investment Banks/BrokersFinance MTS Health Partners LP provides strategic and financial advisory services to healthcare companies from global corporations to venture backed businesses. Its strategic advisory alternatives include mergers, acquisitions, company sales, divestitures, recapitalizations, restructurings, general strategic advisory, financing oversight and oversight opinions. The firms financing solutions include traditional private convertible preferred issuances, cross-over focused convertible transactions, common stock and structured/convertible PIPEs, registered direct and acquisition financings, secondary sales, special situations, structured debt financings and royalty monetization. The company was founded by Curtis Scott Lane in 2000 and is headquartered in New York, NY. | Finance |
DNAnexus, Inc.
DNAnexus, Inc. Packaged SoftwareTechnology Services DNAnexus, Inc. develops a cloud-based data analysis and management platform for DNA sequence data. It engages in the provision of cloud-based solutions for large-scale Deoxyribonucleic acid (DNA) data management and analysis. The firm offers a centralized hub for managing data, collaborating with other scientists, sharing tools, and accessing diverse reference datasets, including genotypic and phenotypic data. The company was founded by Serafim Batzoglou, Andreas Sundquist and Arend Sidow in 2009 and is headquartered in Mountain View, CA. | Technology Services |
RTW Investments /Venture/
RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Finance |
RTW Investments ICAV | Miscellaneous |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. is a Chinese company that develops and commercializes novel therapeutics. Yan Ping Mou has been the CEO of the company since 2023. | Health Technology |
- Stock Market
- Insiders
- Bradley Sitko